Pharmaceuticals Companies By Pb Ratio
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Book
| Price To Book | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | VRCA | Verrica Pharmaceuticals | (0.30) | 6.87 | (2.05) | ||
| 2 | RDHL | Redhill Biopharma | 0.07 | 15.34 | 1.03 | ||
| 3 | AMRX | Amneal Pharmaceuticals, Class | 0.16 | 2.51 | 0.40 | ||
| 4 | LLY | Eli Lilly and | 0.05 | 2.34 | 0.12 | ||
| 5 | EOLS | Evolus Inc | 0.25 | 2.88 | 0.72 | ||
| 6 | AXSM | Axsome Therapeutics | 0.17 | 1.95 | 0.33 | ||
| 7 | NVO | Novo Nordisk AS | 0.00 | 2.38 | (0.01) | ||
| 8 | EYEN | Eyenovia | 0.01 | 8.28 | 0.09 | ||
| 9 | OGN | Organon Co | 0.02 | 2.34 | 0.04 | ||
| 10 | SCLX | Scilex Holding | (0.19) | 5.28 | (1.01) | ||
| 11 | SCPH | Scpharmaceuticals | 0.12 | 4.29 | 0.52 | ||
| 12 | WVE | Wave Life Sciences | 0.01 | 4.59 | 0.07 | ||
| 13 | PHAT | Phathom Pharmaceuticals | 0.23 | 4.03 | 0.92 | ||
| 14 | HROW | Harrow Health | 0.22 | 7.65 | 1.66 | ||
| 15 | OPTN | OptiNose | (0.09) | 3.74 | (0.35) | ||
| 16 | BHC | Bausch Health Companies | 0.01 | 3.72 | 0.04 | ||
| 17 | AVDL | Avadel Pharmaceuticals PLC | (0.08) | 2.26 | (0.17) | ||
| 18 | ZTS | Zoetis Inc | 0.13 | 1.46 | 0.19 | ||
| 19 | SEEL | Seelos Therapeutics | (0.17) | 11.22 | (1.94) | ||
| 20 | VRNA | Verona Pharma PLC | 0.23 | 4.62 | 1.07 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities. Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.